Poster presentation of preliminary data from the Phase 2a investigator-initiated study UCORIS in ulcerative colitis (UC) at the 20th ECCO Congress UC is a chronic inflammatory bowel disease that causes inflammation and ulcers (sores) in the lower digestive tract with limited efficacious...
Hence then, the article about union therapeutics announces presentation of preliminary data from phase 2a investigator initiated study with orismilast in ulcerative colitis at the 20th ecco congress was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( UNION therapeutics announces presentation of preliminary data from Phase 2a investigator-initiated study with orismilast in ulcerative colitis at the 20th ECCO Congress )
Also on site :
- AI robots could cost $13,000 by 2035: Here’s what that means for CFOs
- Facebook and Instagram owner enabled child sexual exploitation
- Mick Jagger Sings 9 Words About Dreams We All Need to Hear